Metraipolis › archive › dc_046fd2899876

Antibody-drug conjugates in cancer therapy: do we need biomarkers? A comprehensive review — Europe PMC PMID:42185658

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42185658
DOI
10.1007/s10555-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-01T07:40:51.943Z
SHA-256 of the archived text
374a6bc9356f11dd314776b5a2f6e2560318e79cf35bf5989e582b6f5ba3e42f
Stable URL of this page
https://metraipolis.com/documento/dc_046fd2899876

How to cite

Antibody-drug conjugates in cancer therapy: do we need biomarkers? A comprehensive review — Europe PMC PMID:42185658 — Europe PMC (en), https://europepmc.org/article/MED/42185658 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_046fd2899876 (Metraipolis archive dc_046fd2899876, sha256 374a6bc9356f11dd314776b5a2f6e2560318e79cf35bf5989e582b6f5ba3e42f)
BibTeX
@misc{dc046fd2899876,
  title = {Antibody-drug conjugates in cancer therapy: do we need biomarkers? A comprehensive review — Europe PMC PMID:42185658},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42185658},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_046fd2899876; sha256 374a6bc9356f11dd314776b5a2f6e2560318e79cf35bf5989e582b6f5ba3e42f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42185658. Agents can read the archived copy with the MCP tool read_document.